| Application no. and date | 03792521.1 (espacenet) (Federated) (European Patent Register), 20030822 | | Patent/reg. no. and date | DK/EP 1545516, 20080903 | | Publication date | 20050629 | | Priority no. and date | US 406351 P, 20020826 | | EP pub. no. and date |
EP 1545516 20050629 | | Effective date | | | Applicant/owner | S.L.A. Pharma AG, Rebgasse 2
4410 Liestal, CH | | Applicant ref. no. | PA 85882 | | Inventor | ARMSTRONG, David, Nigel, 7410 Princeton Trace
Atlanta, GA 30328, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/4164 (2006.01) , A61K 47/06 (2006.01) , A61K 9/06 (2006.01) , A61P 1/04 (2006.01) , A61P 17/02 (2006.01) , A61P 31/04 (2006.01) | | Title | Topisk formulering omfattende mindst 10% metronidazol i vaseline og anvendelse heraf i det anale og rektale område | | Int. application no. | GB2003003692 | | Int. publication no. | WO2004017962 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
